![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 47, 48808-48816, November 19, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1-induced Migration*


¶
¶




From the
Department of Human and Animal Biology, University of Torino, Torino 10123, Italy, the ||Department of Medical Sciences, University of Piemonte Orientale, Novara 28100, Italy, and the **Department of Pharmacological Sciences, University of Milan, Milan 20133, Italy
Activation of the receptor tyrosine kinase ErbB4 leads to various cellular responses such as proliferation, survival, differentiation, and chemotaxis. Two pairs of naturally occurring ErbB4 isoforms differing in their juxtamembrane (JMa/JMb) and C termini (cyt1/cyt2) have been described. To examine the role of ErbB4 in neuron migration, we cloned and stably transfected each of the four ErbB4 isoforms in ST14A cells (a neural progenitor cell line derived from the striatum of embryonic day 14 rats) endogenously expressing the other members of the ErbB family: ErbB1, ErbB2, and ErbB3. Using immunoprecipitation assays, we showed that the neuregulin-1
1 (NRG1
1) stimulus induced ErbB4 tyrosine phosphorylation and phosphatidylinositol 3-kinase (PI3K) recruitment and activation (as demonstrated by Akt phosphorylation) either directly (ErbB4 cyt1 isoform) or indirectly (ErbB4 cyt2 isoform). We examined the ability of the four ErbB4 isoforms to induce chemotaxis and cell proliferation in response to NRG1
1 stimulation. Using migration assays, we observed that only ErbB4-expressing cells stimulated with NRG1
1 showed a significant increase in migration, whereas the growth rate remained unchanged. Additional assays showed that inhibition of PI3K (but not of phospholipase C
) dramatically reduced migratory activity. Our data show that ErbB4 signaling via PI3K activation plays a fundamental role in controlling NRG1
1-induced migration.
Received for publication, July 23, 2004 , and in revised form, August 24, 2004.
* This work was supported by a grant from the Compagnia di S. Paolo, (Grant MIUR-PRIN 2001), and PRONEURO (Grant FIRB RBNE01WY7P). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AY375306
¶ Both authors contributed equally to this work.
To whom correspondence should be addressed: Dipt. di Biologia Animale e dell'Uomo, Università degli Studi di Torino, Via Accademia Albertina 13, 10123 Torino, Italia. Tel.: 39-11-670-4688; Fax: 39-11-670-4692; E-mail: giovanna.gambarotta{at}unito.it.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R.-H. Tao and I. N. Maruyama All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells J. Cell Sci., October 1, 2008; 121(19): 3207 - 3217. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Wang, C. Sloss, X. Zhang, S. W. Lee, and J. C. Cusack Membrane-Bound Heparin-Binding Epidermal Growth Factor Like Growth Factor Regulates E-Cadherin Expression in Pancreatic Carcinoma Cells Cancer Res., September 15, 2007; 67(18): 8486 - 8493. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Law, J. E. Kleinman, D. R. Weinberger, and C. S. Weickert Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia Hum. Mol. Genet., January 15, 2007; 16(2): 129 - 141. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |